Latest Market Data
Hang Seng Index
23,601.26
+56.95 (+0.24%)
HSCEI
8,583.86
+26.22 (+0.31%)
Hang Seng TECH Index
5,246.87
-4.88 (-0.09%)
Hang Seng HKEX Stock Connect China Enterprises Index
3,937.47
-14.02 (-0.35%)
MSCI China A 50 Connect Index
2,142.75
-14.82 (-0.69%)
HSI Volatility Index
23.07
-0.64 (-2.70%)
CSI 300 Index
3,882.27
-31.59 (-0.81%)
CES China120 Index
6,533.96
-26.12 (-0.40%)
USD/CNH Spot
7.1699
-0.0008 (-0.01%)
USD/INR Spot
85.1720
-0.7950 (-0.92%)
HKEX Bitcoin Reference Index
108,150.02
+524.01 (+0.49%)
HKEX Ether Reference Index
2,510.77
-36.68 (-1.44%)
CNH Gold Futures – Spot Price Index
-
- (-)
USD Gold Futures – Spot Price Index
-
- (-)
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. (460)

SIHUAN PHARM (460)

HK$0.890

-0.020 (-2.20%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$0.910
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$0.920
TURNOVER
HK$180.84M
VOLUME
200.37M
MKT CAP
HK$8.20B
LOT SIZE
1,000
BID
HK$0.890
ASK
HK$0.900
EPS
-
P/E
-
DIV YIELD
2.36%
INTRA-DAY 52W
High HK$0.930 HK$1.020
Low HK$0.880 HK$0.495
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 23 May 2025 16:08 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.004M8M10:0011:0012:0013:0014:0015:0016:000.8600.8800.9000.9200.940Prev. Close
0.910
All charts use the last traded price or closing price.

COMPANY PROFILE

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company primarily engaged in the research and development, manufacture and sale of pharmaceutical products and aesthetic products. The Company operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The Company conducts its business in the domestic and overseas markets. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 9,213,584,206 (as at 12 May 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Pharmaceuticals Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Listing Date 28 Oct 2010
Financial Year Ends 31 Dec 2024
Chairman Che Fengsheng
Principal Office Room 4905, Office Tower
Convention Plaza
1 Harbour Road
Wan Chai, Hong Kong
Place of Incorporation Bermuda
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 25 May 2025 08:03 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
28 Mar 2025-No Dividend for the period ended
2024/12/31
31 Dec 2024--
30 Aug 202427 Sep 2024Int (Semi-annual)
Div RMB 0.019
(HKD 0.021)
31 Dec 202402 Oct 2024 - 03 Oct 202410 Oct 2024
28 Mar 2024-No Dividend for the period ended
2023/12/31
31 Dec 2023--
29 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
24 Mar 202306 Jun 2023Fin Div RMB 0.032
(HKD 0.037)
31 Dec 202208 Jun 2023 - 09 Jun 202323 Jun 2023
LOAD MORE
Updated: 24 May 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews